
TRAWS PHARMA INC
TRAW · NASDAQ
Updated at 2026-10-13 15:23:11
- Today's High
- $0.43
- Today’s Low
- $0.40
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.43
- Previous Close
- $0.41
- Volume
- 178.37K
- Market Cap
- $6.39M
- P/E Ratio
- --
- EPS
- $-2.10
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 12 PENNS TRAIL, NEWTOWN, PA, UNITED STATES, 18940
- Country
- US
- Listing Date
- 2013-07-25
- Fiscal Year End
- December
- Shares Outstanding
- 15.23M
- CIK
- 0001130598
- Website
- www.trawspharma.com
Traws Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer in the United States. The company is headquartered in Newtown, Pennsylvania.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$57K
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$3.17M
2026-03-31
$6.94M
2025-12-31
$7.36M
2025-09-30
$4.05M
Net Income
2026-06-30
-$3.05M
2026-03-31
-$3.05M
2025-12-31
-$7.44M
2025-09-30
-$3.03M
Net Profit Margin
2026-06-30
--
2026-03-31
-5.35K%
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.16
2026-03-31
$-0.52
2025-12-31
$-0.55
2025-09-30
$-0.34
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$3.13M
2026-03-31
-$6.9M
2025-12-31
-$7.32M
2025-09-30
-$3.96M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $57K | $0 | $0 |
| Operating Expenses | $3.17M | $6.94M | $7.36M | $4.05M |
| Net Income | -$3.05M | -$3.05M | -$7.44M | -$3.03M |
| Net Profit Margin | -- | -5.35K% | -- | -- |
| Earnings Per Share | $-0.16 | $-0.52 | $-0.55 | $-0.34 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$3.13M | -$6.9M | -$7.32M | -$3.96M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.